Businesses that produce bioscience products--gene tests and therapies,
pharmaceuticals, vaccines, and medical devices--are regularly confronted
with ethical issues concerning these technologies. Conflicts exist
between those who support advancements in bioscience and those who fear
the consequences of unfettered scientific license. As the debate
surrounding bioscience grows, it will be increasingly important for
business managers to consider the larger consequences of their work.
This groundbreaking book follows industry research, development, and
marketing of medical and bioscience products across a variety of fields,
including biotechnology, pharmaceuticals, and bio-agriculture.
Compelling and current case studies highlight the ethical decisions
business managers frequently face. With the increasing visibility and
public expectation placed on businesses in this sector, managers need to
understand the ethical and social issues. This book addresses that need
and provides a framework for incorporating ethical analysis in business
decision making.